GISAR German Interdisciplinary Sarcoma Registry

Launched by INSTITUT FÜR KLINISCHE KREBSFORSCHUNG IKF GMBH AT KRANKENHAUS NORDWEST · Oct 9, 2019

Keywords

ClinConnect Summary

The GISAR German Interdisciplinary Sarcoma Registry is a clinical trial that aims to collect important information about patients with sarcoma, which is a type of cancer that can affect bones and soft tissues. By gathering data from patients treated in Germany, the study hopes to better understand how different treatments work and their side effects. This registry is open to all adults, starting from age 18, who have been diagnosed with specific types of sarcomas, including those with borderline or unclear results.

If you join this trial, you will be asked to provide some basic information about your health, and depending on your specific situation, more detailed data may also be collected to answer particular scientific questions. The study is currently recruiting participants, and there are no specific exclusion criteria, so most people meeting the inclusion criteria can take part. Your participation could help improve the understanding and treatment of sarcoma for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Histological verified bone or soft tissue sarcomas including bone and soft tissue tumors with borderline histological results or with unclear histological dignity like giant cell tumors of the bone (GCTB), desmoid tumors, atypical lipomatous tumors etc. - independent of therapy form and therapy line - or Histological verified sarcomatoid carcinomas/ carcinosarcomas: tumors with histological, cytological, or molecular properties of both epithelial tumors ("carcinoma") and mesenchymal tumors ("sarcoma") - independent of therapy form and therapy line.
• • Signed informed consent form or equivalent (s. chapter 10)
• • Age ≥18 years
• Exclusion Criteria:
• • none